Aldeyra Therapeutics Statistics
Total Valuation
ALDX has a market cap or net worth of $312.56 million. The enterprise value is $247.86 million.
Important Dates
The next estimated earnings date is Friday, November 8, 2024, before market open.
Earnings Date | Nov 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ALDX has 59.42 million shares outstanding. The number of shares has increased by 1.03% in one year.
Shares Outstanding | 59.42M |
Shares Change (YoY) | +1.03% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 2.59% |
Owned by Institutions (%) | 35.40% |
Float | 43.13M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 3.18 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.55, with a Debt / Equity ratio of 0.16.
Current Ratio | 4.55 |
Quick Ratio | 2.91 |
Debt / Equity | 0.16 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -21.22 |
Financial Efficiency
Return on equity (ROE) is -33.19% and return on invested capital (ROIC) is -20.70%.
Return on Equity (ROE) | -33.19% |
Return on Assets (ROA) | -19.11% |
Return on Capital (ROIC) | -20.70% |
Revenue Per Employee | n/a |
Profits Per Employee | -$3.79M |
Employee Count | 10 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +241.56% in the last 52 weeks. The beta is 1.43, so ALDX's price volatility has been higher than the market average.
Beta (5Y) | 1.43 |
52-Week Price Change | +241.56% |
50-Day Moving Average | 5.59 |
200-Day Moving Average | 4.20 |
Relative Strength Index (RSI) | 44.40 |
Average Volume (20 Days) | 383,854 |
Short Selling Information
The latest short interest is 3.40 million, so 5.73% of the outstanding shares have been sold short.
Short Interest | 3.40M |
Short Previous Month | 3.00M |
Short % of Shares Out | 5.73% |
Short % of Float | 7.89% |
Short Ratio (days to cover) | 7.52 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -43.05M |
Pretax Income | -37.87M |
Net Income | -37.87M |
EBITDA | -42.80M |
EBIT | -43.05M |
Earnings Per Share (EPS) | -$0.64 |
Full Income Statement Balance Sheet
The company has $80.33 million in cash and $15.64 million in debt, giving a net cash position of $64.70 million or $1.09 per share.
Cash & Cash Equivalents | 80.33M |
Total Debt | 15.64M |
Net Cash | 64.70M |
Net Cash Per Share | $1.09 |
Equity (Book Value) | 98.31M |
Book Value Per Share | 1.65 |
Working Capital | 98.05M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -30.72M |
Capital Expenditures | n/a |
Free Cash Flow | -30.72M |
FCF Per Share | -$0.52 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |